Finally, the free lunch?
Orlistat, the first drug intended to control weight by interfering with the uptake of fat, is under consideration for approval by the FDA, and last week the manufacturer, Hoffmann La Roche, announced
Orlistat, the first drug intended to control weight by interfering with the uptake of fat, is under consideration for approval by the FDA, and last week the manufacturer, Hoffmann La Roche, announced